These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 30639526)
1. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports. Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Chen SC; Kong DCM Int J Antimicrob Agents; 2019 May; 53(5):589-597. PubMed ID: 30639526 [TBL] [Abstract][Full Text] [Related]
2. Mucormycosis: New Developments into a Persistently Devastating Infection. Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579 [TBL] [Abstract][Full Text] [Related]
5. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China]. Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732 [TBL] [Abstract][Full Text] [Related]
6. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. Riley TT; Muzny CA; Swiatlo E; Legendre DP Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416 [TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases. Wang J; Liu L; Li J; Feng X; Yi H; Jiang E; Zheng Y; Zhang F; Zhu X; Mi Y; Han M; Wang J; Feng S Mycopathologia; 2024 Aug; 189(4):71. PubMed ID: 39088077 [TBL] [Abstract][Full Text] [Related]
9. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy. Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881 [TBL] [Abstract][Full Text] [Related]
10. Mucormycosis in Mainland China: A Systematic Review of Case Reports. Wei LW; Zhu PQ; Chen XQ; Yu J Mycopathologia; 2022 Feb; 187(1):1-14. PubMed ID: 34855101 [TBL] [Abstract][Full Text] [Related]
11. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Chitasombat MN; Kontoyiannis DP Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199 [TBL] [Abstract][Full Text] [Related]
12. Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis-An Exploratory Study. Dandu H; Kumar N; Kumar N; Malhotra HS; Prabhu V; Bharti VR; Gupta P; Yadav G; Verma V Mycopathologia; 2024 Jun; 189(4):54. PubMed ID: 38865003 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008 [TBL] [Abstract][Full Text] [Related]
14. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]
15. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E; BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748 [TBL] [Abstract][Full Text] [Related]
16. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease. Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785 [TBL] [Abstract][Full Text] [Related]
17. [Mucormycosis: therapeutic news]. Pilmis B; Lanternier F; Lortholary O Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522 [TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole. Camargo JF; Yakoub D; Cho-Vega JH Mycopathologia; 2015 Oct; 180(3-4):187-92. PubMed ID: 26112998 [TBL] [Abstract][Full Text] [Related]
19. Cerebral mucormycosis in a diabetic man. Uy EM; Rustagi T; Khera S Conn Med; 2011 May; 75(5):273-9. PubMed ID: 21678839 [TBL] [Abstract][Full Text] [Related]
20. Sinonasal mucormycosis: case report. Mimouni O; Curto CL; Danvin JB; Thomassin JM; Dessi P Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Mar; 127(1):27-9. PubMed ID: 20822753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]